ObjectiveHealth, QualDerm Expand Partnership to Enhance Patient Care Options

ObjectiveHealth, a Nashville-based integrated research and technology platform company, has announced an expansion of its partnership with QualDerm Partners, LLC, a leading dermatology and skin care management services organization also based in Nashville. This collaboration aims to integrate clinical research…

Read MoreObjectiveHealth, QualDerm Expand Partnership to Enhance Patient Care Options

Brenus Pharma Earns Global Cancer Stream Accreditation 2023/2024 from Creative Destruction Lab & NA Universities

Last year, Brenus Pharma was chosen to join CDL Cancer, a global mentoring program supporting highly scalable, science-driven companies advancing cancer treatments. Distinguished by its innovative STC platform focused on developing next-generation therapeutic cancer vaccines, Brenus impressed during a rigorous…

Read MoreBrenus Pharma Earns Global Cancer Stream Accreditation 2023/2024 from Creative Destruction Lab & NA Universities

Augustine Therapeutics Secures EUR 17M for Clinical Development in Neurological Diseases

Augustine Therapeutics, a pioneering biotech firm dedicated to innovative therapies for neurodegenerative and cardiometabolic diseases, has successfully secured EUR 17 million (USD 18.5 million) in the initial closing of its Series A funding round. The financing was led by Asabys…

Read MoreAugustine Therapeutics Secures EUR 17M for Clinical Development in Neurological Diseases

Greenspace Health Partners Teams Up with Behavioral Health Innovations for Digital Assessments

Greenspace Health and Behavioral Health Innovations (BHI) have announced a strategic partnership aimed at enhancing access to BHI’s evidence-based assessments through digital platforms. This collaboration seeks to streamline the administration of assessments such as the UCLA PTSD Reaction Index, crucial…

Read MoreGreenspace Health Partners Teams Up with Behavioral Health Innovations for Digital Assessments